Navigation Links
Quit Smoking

Although even diehard smokers may insist that they "enjoy" their habit and don't fear the health consequences, don't believe them. Since smoking involves powerful physiological and psychological addictions, quitting is very difficult, and without help only a minority succeed. Even smoking cessation courses, nicotine gum and patches, while helpful to many, have been unable to keep the majority permanently away from cigarettes. Foreign studies have shown that despite treatment advances to help people stop smoking, 70% to 80% of smokers who stop relapse within six to 12 months. //

But now an anti-depressant drug called bupropion - known commercially here as Zyban and made by GlaxoSmithKline - is showing considerable promise in helping smokers butt tobacco out of their lives for good. In the study 784 participants took bupropion to help them stop smoking. After seven weeks of treatment 461 participants had successfully stopped. Half of that group continued with bupropion for a year, and the other half took a placebo. At year's end, 55% of the group continuing to take bupropion were abstinent, compared to 42% in the placebo group.

Zyban has been licensed as a prescription drug by the Health Ministry. But the dosage of the active ingredient in Zyban is significantly less than the amount taken for depression, he added. Two Zyban pills (totalling 300 milligrams) are taken every day for about nine weeks. The unsubsidized cost of the drug is about the same as the expense of buying a pack of cigarettes a day.

The drug poses possible side effects such as dry mouth, headache and insomnia, but half of users suffer none of them and in most of those who do the effects are short-lived and not serious. It should not be taken by pregnant or lactating women, or people who have epilepsy or anorexia or are alcoholics.


'"/>




Page: 1

Related medicine news :

1. New hope on the Horizon for People Wishing to Quit Smoking
2. Cancers of Colon & Rectum linked to Cigarette Smoking
3. Smoking a greater risk than HIV? Yes say health experts!!!!
4. Kick Smoking with Nicotine Drink
5. Smoking spreads Cancer
6. Prescription Drug - Helps People Stop Smoking
7. Smoking can depreciate intellegence
8. Smoking Delays Pregnancy
9. Smoking Linked To Low Infant Birth Weight
10. GlaxoSmithKline To Cultivate Non-Smoking Environment
11. Smoking stripes longevity
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2016)... ... December 05, 2016 , ... The new knee compression sleeves ... to buy neoprene knee sleeves for lifting and any sport that requires ... on two main aspects to provide a higher quality knee sleeve performance. Firstly it ...
(Date:12/5/2016)... , ... December 05, 2016 , ... ... today that they have teamed up with The American College of Surgeons (ACS) ... ACS’s Committee on Trauma, the “Bleeding Control Basic” course is a pilot program ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... and many more tools allowing FCPX editors to create professional looking video in ... , Perfect Harmony contains a beautifully designed 3D environment for placing in ...
(Date:12/4/2016)... ... December 04, 2016 , ... "Pro3rd Displace ... animation styles with unique displacement design elements," said Christina Austin - CEO of ... Choose from a variety of design styles that include both left aligned and ...
(Date:12/2/2016)... ... 2016 , ... Halfway through its partnership with First 5 LA, Western University ... than 15,900 children 5 years old and younger and treatment services to more than ... of five years to Western University of Health Sciences, UCLA and USC, beginning March ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , December 5, 2016 PharmaBoardroom today releases ... . ... This report offers companies, investors, policymakers, and stakeholders crucial insight ... of Europe , home to some of the world,s ... pharmaceutical companies in Novartis and Roche, and with a number one ranking ...
(Date:12/5/2016)... VIENNA and TAIPEI, Taiwan , ... 12 months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea ... demonstrated a significantly better safety and tolerability profile of ropeginterferon ... data from PROUD-PV and the ongoing long-term follow-up trial CONTINUATION-PV ... PharmaEssentia intends to present this data to the ...
(Date:12/4/2016)... ORLEANS , Dec. 2, 2016  Former Attorney General ... Jr., Esq. , a partner at the law firm of ... commenced an investigation into Lannett Company, Inc. (NYSE: ... Bloomberg published an article titled "U.S. Charges in Generic-Drug ... "antitrust investigation by the Justice Department, begun about two years ...
Breaking Medicine Technology: